Optical Characterization of Sodium Fluorescein In Vitro and Ex Vivo

Autor: Xu, Ran, Teich, Wanda, Frenzel, Florian, Hoffmann, Katrin, Radke, Josefine, R��sler, Judith, Faust, Katharina, Blank, Anne, Brandenburg, Susan, Misch, Martin, Vajkoczy, Peter, Onken, Julia Sophie, Resch-Genger, Ute

Objective: The utilization of fluorescein-guided biopsies and resection has been recently discussed as a suitable strategy to improve and expedite operative techniques for the resection of central nervous system (CNS) tumors. However, little is known

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c14f85ec04c807fd93d789fcf35eae43
https://doi.org/10.17169/refubium-32274

Optical Characterization of Sodium Fluorescein In Vitro and Ex Vivo .

Autor: Xu R; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Teich W; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Frenzel F; Division Biophotonics, Federal Institute for Materials Research and Testing (BAM), Berlin, Germany., Hoffmann K; Division Biophotonics, Federal Institute for Materials Research and Testing (BAM), Berlin, Germany., Radke J; Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany, partner site Charité Berlin, Berlin, Germany.; Berlin Institute of Health (BIH), Berlin, Germany., Rösler J; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Faust K; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Blank A; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Brandenburg S; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Misch M; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Vajkoczy P; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Onken JS; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany, partner site Charité Berlin, Berlin, Germany., Resch-Genger U; Division Biophotonics, Federal Institute for Materials Research and Testing (BAM), Berlin, Germany.

Publikováno v: Frontiers in oncology [Front Oncol] 2021 May 10; Vol. 11, pp. 654300. Date of Electronic Publication: 2021 May 10 (Print Publication: 2021).